Pharmacology and Therapeutics
-
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
This article has 9 authors:Reviewed by ScreenIT
-
Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model
This article has 9 authors:Reviewed by ScreenIT
-
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
This article has 3 authors:Reviewed by ScreenIT
-
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease
This article has 10 authors:Reviewed by ScreenIT
-
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
This article has 17 authors:Reviewed by ScreenIT
-
Deleterious drugs in COVID-19: a rapid systematic review and meta-analysis
This article has 5 authors:Reviewed by ScreenIT
-
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
This article has 3 authors:Reviewed by ScreenIT
-
An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2
This article has 34 authors:Reviewed by ScreenIT
-
A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19
This article has 38 authors:Reviewed by ScreenIT
-
The efficacy and safety of bamlanivimab treatment against COVID-19: A meta-analysis
This article has 6 authors:Reviewed by ScreenIT